Fatty15 for Weight Loss: Does It Actually Help?

Fatty15 for Weight Loss: Does It Actually Help?

Some people take Fatty15 hoping it will help with weight, so it’s worth being clear: Fatty15 is not a weight-loss supplement, and it isn’t marketed as one by the company. Its ingredient, C15 (pentadecanoic acid), has been researched for metabolic health, which is related to but not the same as weight loss. Here’s what the evidence actually supports.

What the Research Shows on C15 and Metabolism

Research has linked higher C15 levels to lower type 2 diabetes risk in cohort studies, and has looked at metabolic markers, things like ^[1][2][3][4]insulin sensitivity and lipid profiles, where findings are mixed [4]^[3]. Preclinical work suggests C15 interacts with metabolic pathways (including PPAR receptors involved in fat and glucose handling). These are metabolic-health signals, not demonstrated fat-loss effects in humans.

Why Metabolic Health Isn’t the Same as Weight Loss

Improving metabolic markers can support overall health and, indirectly, a healthier body composition over time, but it does not mean a supplement burns fat or reduces appetite. No robust human trial shows Fatty15 causing weight loss. Anyone selling it as a fat-burner is overstating the science.

Could It Help Indirectly?

Possibly, at the margins. If C15 supports metabolic function and cell health, it may be a small supporting player in an overall healthy-lifestyle picture. But the drivers of weight change remain diet, activity, sleep, and overall calorie balance. Treat Fatty15 as a general-health supplement, not a weight strategy.

Does Fatty15 Cause Weight Gain?

No, this is a common worry because it’s a “fat.” The per-dose amount of fat is tiny (a single fatty acid), but the evidence is not uniformly favorable: in pregnant mice a C15-enriched diet caused mild insulin resistance and offspring grew faster. Those are mouse findings, and there is no human evidence that it causes weight gain ^[5][6].

The Honest Takeaway

Fatty15 may support metabolic health, but it is not a weight-loss product and shouldn’t be bought as one. If metabolic health is your goal, C15 is an under-studied nutrient that may be worth discussing with your clinician ^[2][7], and you can get the molecule affordably via a generic C15 supplement. For the full picture, see our Fatty15 review.

What the Two 2024 Human Trials Actually Measured

If you want to know whether pentadecanoic acid affects body weight in people, there are two randomized trials worth reading closely, and neither was designed as a weight-loss test. A 2024 trial in the Journal of Nutrition (Robinson et al.) enrolled 30 young adults with overweight or obesity (mean BMI about 33) and gave 20 of them 200 mg of C15 daily and 10 a placebo for 12 weeks. The trial was supported by Seraphina Therapeutics, which supplied the capsules ^[8]. Its stated primary goal was to see whether blood C15 rose, with safety and a set of physiologic markers as secondary aims. The published abstract does not report a change in body weight, so the trial neither shows nor rules out an effect on the scale. What it did report: blood C15 rose more in the treatment group, no significant adverse events occurred, and among the half of the treated group whose final level passed 5 micrograms per mL, liver enzymes fell and hemoglobin rose compared with the participants who did not reach that level.

That last comparison is a split by outcome in a small group, so it is a signal for future research rather than a finding that C15 changes metabolism in people with obesity. Apart from a drop in the liver enzyme GGT, the trial found no other significant differences between C15 and placebo in its secondary outcomes ^[8].

The second trial, TANGO, was published in the American Journal of Clinical Nutrition in 2024 (Chooi et al.). It randomized 88 Chinese women with fatty liver disease to one of three groups for 12 weeks: a Mediterranean-style Asian diet plus C15, the same diet without C15, or their habitual diet. Weight fell by 4.0 kg (5.3 percent) with diet plus C15, 3.4 kg (4.5 percent) with diet alone and 1.5 kg (2.1 percent) in the control group. Both diet groups lost significantly more weight and liver fat than the control group. The authors credit the diet for those benefits. What they attribute to C15 specifically is a further drop in LDL cholesterol and a rise in a gut bacterium, Bifidobacterium adolescentis. In plain terms, the women lost weight because they changed how they ate.

Population Studies: Diabetes Risk Is Not Body Weight

The research behind the “metabolic health” language mostly comes from cohort studies that measure C15 in blood and follow people for years. In the EPIC-InterAct case-cohort study across Europe (published in Lancet Diabetes and Endocrinology in 2014), higher plasma phospholipid C15 was associated with a lower risk of type 2 diabetes, with a hazard ratio of 0.79 per standard deviation, while even-chain saturated fats such as palmitic acid pointed the other way. A later pooled analysis of 16 prospective cohorts and 63,682 participants (PLoS Medicine, 2018) found a hazard ratio of 0.80 across the 10th to 90th percentile range of C15 after adjusting for BMI and waist circumference. A separate cross-sectional EPIC-InterAct analysis found that higher odd-chain levels went with lower triglycerides and lower liver enzymes.

Two cautions apply. First, blood C15 largely tracks dairy fat intake, so these studies cannot separate C15 from everything else people who eat dairy do, and the pooled analysis itself notes that residual confounding may exist. Second, these studies adjusted for body size to ask whether C15 relates to diabetes beyond weight. That is a different question from whether taking C15 helps you lose it.

The diabetes link is also less firm than a single hazard ratio suggests. An umbrella review graded the evidence for C15 only as suggestive, a meta-analysis of C15 and diabetes had high heterogeneity (I2 = 72.9 percent), and in men in one German cohort a C15-containing lipid was linked to higher diabetes risk (HR 1.96) ^[7][9][10].

Animal Data Is Mixed, Which Is Itself Informative

It is tempting to assume every animal result points the same direction. A 2024 study in Food and Function fed pregnant mice a diet containing 1 percent C15 by weight. During lactation the mothers deposited less body fat, which sounds favorable, but the same animals developed mild insulin resistance and oxidative stress, and their pups grew faster. A 2025 paper in the same journal reported mild glucose intolerance in pregnant mice on a high-fat diet given the supplement. These were mice, in pregnancy, at a dose that is large relative to ordinary diet, so they say little about a typical adult. They do show that the effect of this fatty acid on energy balance and glucose handling is not uniformly favorable in every setting, which is a reason for caution about any weight-related claim.

What the Brand Says About Appetite and Calories

Fatty15’s FAQ answers the weight question directly. As of October 2026, the page says one capsule has less than 1 calorie, and that by helping cells work more efficiently the body can get busy expending energy instead of storing it as fat. The same FAQ lists less snacking and hunger between meals among benefits some customers report within the first few weeks. These are brand statements carrying the standard disclaimer that they have not been evaluated by the FDA. None of the published abstracts read for this article report appetite, hunger or energy expenditure as a measured outcome, so the claim currently rests on the company’s description and customer reports, not on a controlled trial.

If Weight Is Your Goal, Where Does C15 Fit?

The trial evidence supports a modest framing. Diet change produced the weight loss in TANGO. C15 added changes in LDL cholesterol and gut bacteria within a diet program, which are different endpoints. The one placebo-controlled supplement-only trial in people with obesity used 200 mg a day, twice the 100 mg in one Fatty15 capsule (the brand suggests starting with one or two capsules a day), and its abstract did not report weight.

• Treat sleep, activity, protein, fiber and total calories as the levers that move weight.
• If you are curious about C15 for liver or cholesterol markers, ask a clinician to track those markers, not the scale.
• Be skeptical of any listing that promises appetite suppression or fat burning from a single fatty acid.

Frequently Asked Questions

Does Fatty15 help with weight loss?

Not directly. Fatty15’s ingredient (C15) is researched for metabolic markers, not fat loss, and no human trial shows it causing weight loss. It’s a general-health supplement, not a weight-loss aid.

Does Fatty15 cause weight gain?

No. The fat content per dose is tiny, and the trials reviewed here did not report weight gain, though mouse studies in pregnancy found mild insulin resistance and glucose intolerance ^[5][6].

Can Fatty15 improve metabolism?

Observational research links higher C15 to lower type 2 diabetes risk, results for lipids are mixed, and preclinical work ^[1][4] suggests it interacts with metabolic pathways. That’s metabolic-health support, not a guaranteed metabolism “boost.”

Should I take Fatty15 to lose weight?

No, choose it for its metabolic and cell-health research, not for weight loss. Weight change is driven by diet, activity, and overall lifestyle.

Did the people in the C15 trials lose weight?

In the TANGO trial, women with fatty liver lost about 4.0 kg with a Mediterranean-style diet plus C15 and 3.4 kg with the diet alone over 12 weeks, and the authors credited the diet for the weight-related benefits. The 2024 Journal of Nutrition trial in young adults with obesity did not report weight in its abstract.

Can C15 reduce hunger?

Fatty15 says some customers report less snacking and hunger between meals, but the published abstracts reviewed here did not measure appetite, so this remains a brand claim and not a demonstrated effect.

Is higher blood C15 linked to lower diabetes risk?

Yes in observational data: pooled cohort studies found about a 20 percent lower risk of type 2 diabetes with higher C15 levels. That is an association, and it does not show that supplementing causes the same benefit.

References

• Robinson MK et al. Pentadecanoic Acid Supplementation in Young Adults with Overweight and Obesity: A Randomized Controlled Trial. The Journal of nutrition (2024). PMID 39069269
• Venn-Watson S et al. Efficacy of dietary odd-chain saturated fatty acid pentadecanoic acid parallels broad associated health benefits in humans: could it be essential? Scientific reports (2020). PMID 32424181
• Chooi YC et al. Effect of an Asian-adapted Mediterranean diet and pentadecanoic acid on fatty liver disease: the TANGO randomized controlled trial. The American journal of clinical nutrition (2024). PMID 38035997
• Forouhi NG et al. Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study. The lancet. Diabetes & endocrinology (2014). PMID 25107467
• Imamura F et al. Fatty acid biomarkers of dairy fat consumption and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies. PLoS medicine (2018). PMID 30303968
• Zheng JS et al. Association between plasma phospholipid saturated fatty acids and metabolic markers of lipid, hepatic, inflammation and glycaemic pathways in eight European countries: a cross-sectional analysis in the EPIC-InterAct study. BMC medicine (2017). PMID 29145892
• Wang J et al. Pentadecanoic acid (C15:0, PA) induces mild maternal glucose intolerance and promotes the growth of the offspring partly through up-regulating liver PPARα and MAPK signaling pathways. Food & function (2024). PMID 39434548
• Wang C et al. Pentadecanoic acid (C15:0) promotes placental angiogenesis by activating the placental PI3K-AKT signaling. Food & function (2025). PMID 41221667

Related: Does Fatty15 Work? · Fatty15 Review · Fatty15 Alternatives

References

1. Imamura F et al. Fatty acid biomarkers of dairy fat consumption and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies. PLoS medicine (2018). PMID 30303968
2. Sellem L et al. Can individual fatty acids be used as functional biomarkers of dairy fat consumption in relation to cardiometabolic health? A narrative review. The British journal of nutrition (2022). PMID 35086579
3. Brian T. Steffen et al. Plasma pentadecanoic acid is modestly related to cardiovascular health in CARDIA and ARIC cohorts: observational associations without evidence of causality. Frontiers in Nutrition (2026). PMID 41743064
4. Mitri J et al. Plasma Free Fatty Acids and Metabolic Effect in Type 2 Diabetes, an Ancillary Study from a Randomized Clinical Trial. Nutrients (2021). PMID 33807135
5. Wang J et al. Pentadecanoic acid (C15:0, PA) induces mild maternal glucose intolerance and promotes the growth of the offspring partly through up-regulating liver PPARα and MAPK signaling pathways. Food & function (2024). PMID 39434548
6. Wang C et al. Pentadecanoic acid (C15:0) promotes placental angiogenesis by activating the placental PI3K-AKT signaling. Food & function (2025). PMID 41221667
7. Chen X et al. Lipid biomarkers for the prediction of type 2 diabetes risk, an umbrella review and updated meta-analyses of prospective observational studies. Frontiers in endocrinology (2026). PMID 42181198
8. Robinson MK et al. Pentadecanoic Acid Supplementation in Young Adults with Overweight and Obesity: A Randomized Controlled Trial. The Journal of nutrition (2024). PMID 39069269
9. Huang L et al. Circulating Saturated Fatty Acids and Incident Type 2 Diabetes: A Systematic Review and Meta-Analysis. Nutrients (2019). PMID 31052447
10. Marcela Prada et al. Association of the odd-chain fatty acid content in lipid groups with type 2 diabetes risk: A targeted analysis of lipidomics data in the EPIC-Potsdam cohort. Clinical Nutrition (2021). PMID 34364238
11. Aglago EK et al. Association between serum phospholipid fatty acid levels and adiposity in Mexican women. Journal of lipid research (2017). PMID 28465289

These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.